AYTU BioPharma, Inc.
AYTU • NASDAQ
AYTU BioPharma, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Joshua R. Disbrow, with a market cap of $25.7M.
CEOJoshua R. Disbrow
Market Cap$25.7M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees150.0
Websiteaytubio.com
Country
United States of America
Next Earnings
No upcoming earnings scheduled for AYTU BioPharma, Inc.
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for AYTU BioPharma, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 3, 2026 | Q2 2026 | -$1.05Est: -$0.40 | -162.5% | $15.2MEst: $12.1M | +25.2% |  10-Q |
| Nov 13, 2025 | Q1 2026 | -$0.08Est: -$0.14 | +42.9% | $13.9MEst: $12.6M | +10.3% | 10-Q |
| Sep 23, 2025 | Q4 2025 | -$0.25Est: -$0.04 | -525.0% | $15.1MEst: $18.0M | -15.8% | 10-K |
| May 14, 2025 | Q3 2025 | $0.21 | — | $18.5MEst: $13.7M | +34.3% | 10-Q |
| Feb 12, 2025 | Q2 2025 | -$0.28Est: $0.00 | — | $16.2MEst: $15.6M | +4.3% | 10-Q |
| Nov 13, 2024 | Q1 2025 | -$0.20Est: -$0.34 | +41.2% | $16.6MEst: $13.8M | +20.4% | 10-Q |
| Sep 26, 2024 | Q4 2024 | -$0.82Est: -$0.45 | -82.2% | $18.0MEst: $18.3M | -1.8% | 10-K |
| May 15, 2024 | Q3 2024 | -$0.52Est: -$0.64 | +18.8% | $18.0MEst: $17.4M | +3.7% | 10-Q |
| Feb 14, 2024 | Q2 2024 | -$0.04Est: -$0.25 | +84.0% | $22.9MEst: $21.7M | +5.5% | 10-Q |
| Nov 14, 2023 | Q1 2024 | -$1.48 | — | $22.1MEst: $27.7M | -20.3% | — |
| Sep 27, 2023 | Q4 2023 | -$0.59Est: -$0.95 | +37.9% | $30.7MEst: $27.7M | +11.0% | 10-K |
| May 11, 2023 | Q3 2023 | -$1.93Est: -$0.63 | -206.3% | $22.7MEst: $28.0M | -18.8% | — |